Cytokinetics Inc. (CYTK) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $79.11 +0.42%
Revenue Growth %: -75.4%
Financial Fact:
Interest and other, net: 111K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -75.4%
Financial Fact:
Interest and other, net: 111K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Cytokinetics Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital on Cytokinetics (CYTK): 'The stock is significantly undervalued despite today's move'
- Ennis (EBF) Reports In-Line Q1 EPS
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
